162 results on '"Haselmann, Verena"'
Search Results
2. Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA
3. Integrated diagnostics
4. Liquid profiling for cancer patient stratification in precision medicine – current status and challenges for successful implementation in standard care
5. Status of liquid profiling in precision oncology – the need for integrative diagnostics for successful implementation into standard care
6. Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at single cell level
7. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
8. Plasma-based S100B testing for management of traumatic brain injury in emergency setting
9. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
10. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
11. Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
12. Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
13. SARS-CoV-2 antibody testing—questions to be asked
14. Correction: Imaging-based characterization of tumoral heterogeneity for personalized cancer treatment
15. Imaging-based characterization of tumoral heterogeneity for personalized cancer treatment
16. Imaging-based characterization of tumoral heterogeneity for personalized cancer treatment.
17. Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients
18. Triptychon: Usability evaluation and implementation of a web-based application for patients' lab and vital parameters.
19. Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines
20. Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome
21. Quality Assurance and Standardization of Cell-Free DNA-Based Prenatal Testing Laboratory Procedures
22. Contributors
23. Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application
24. The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization
25. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
26. Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
27. Identification of CT Imaging Phenotypes of Colorectal Liver Metastases from Radiomics Signatures—Towards Assessment of Interlesional Tumor Heterogeneity
28. Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
29. The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer”
30. Economic assessment of molecular imaging in the oncology treatment process
31. Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection
32. Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care
33. Personalisierte Tumortherapie
34. Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
35. Recruitment of highly functional SARS-CoV-2-specific CD8+T cell receptors mediating cytotoxicity of virus-infected target cells in non-severe COVID-19
36. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
37. Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care.
38. Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis
39. SARS-CoV-2 Antibody Testing - How to Increase the Positive Predictive Value
40. Status of liquid profiling in precision oncology – the need for integrative diagnostics for successful implementation into standard care
41. Liquid profiling for cancer patient stratification in precision medicine – current status and challenges for successful implementation in standard care
42. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing
43. Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
44. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients
45. Comparison of RNA-Based Versus DNA-Based Quantitative KIT D816V Mutation Analysis Reveals Significant Disparity in Patients with Advanced Systemic Mastocytosis
46. Liquid Profiling: Personalisierte Tumortherapie.
47. TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
48. Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy
49. Direct MS-Based Bacterial Identification of Blood Cultures. Comparison of an In-House TritonX-Protocol with Bruker-Sepsityper™
50. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.